JD.com and Ali opened the registration of intention to go to Hong Kong to fight Bivalent Bivalent Vaccine｜Reporter's actual test

Fosun Health, a subsidiary of Fosun Pharma in the Mainland, announced earlier that its online platform has opened the registration of vaccination intentions for the Fubitai bivalent vaccine in Hong Kong. price vaccine.

Fosun Pharma announced on the 4th (Wednesday) that Fosun Health has cooperated with JD Health and Ali Health, and mainland residents can register for personal vaccination intentions in Hong Kong through the JD APP and Alipay APP.

After the customer service text message notifies that the registration is successful, the user can go to Hong Kong to get vaccinated at their own expense.

The reporter of "Hong Kong 01" actually measured the registration procedure of vaccination intention (click to enlarge):

According to the actual measurement by the reporter of "Hong Kong 01" using the Alipay APP, search for "Ali Health Vaccine", and then register the name, age, last recovery time of the new crown, phone number and other information on the page, and the registration can be completed.

Users can also "subscribe to seedling reminders".

The domestic media "Beijing Business Daily" recently reported that some people in Beijing said, "The bivalent vaccine of Fubita is very protective. If I can make an appointment, I would like to go to Hong Kong to receive the bivalent vaccine of Fubita."

"Beijing Business Daily" also reported that some employees who worked in insurance companies said, "Although the Fubitai bivalent vaccine can effectively deal with the original strain and the Omicron mutant strain, I have already been infected. , the antibody level is currently relatively high, and I don't think the need for vaccination is very great."

Wang Peng, a researcher at the Beijing Academy of Social Sciences and a researcher at the Intelligent Social Governance Research Center of Renmin University of China, said, "The launch of the Fubita BNT62b2 vaccine and the Fubita bivalent vaccine in Hong Kong has enriched the diversity of vaccines, and mainland residents can go to Hong Kong for vaccination. Fubitai bivalent vaccine provides more diversified channels and methods for the current epidemic prevention and control, and citizens can also make personalized choices according to their individual needs."

Fosun Health’s Fubitai Bivalent Vaccine Reservation Registration Entrance.

On March 16, 2020, Fosun Pharma and Germany's BioNTech announced that they had reached a strategic cooperation in the development of mRNA vaccines. Fosun Pharma was authorized by BioNTech to develop and commercialize exclusively in China, Hong Kong, Macao and Taiwan based on its proprietary mRNA technology platform The new crown vaccine developed.

In December 2022, the mRNA COVID-19 vaccine Fubita BNT162b2 and the Fubita bivalent vaccine have been registered as pharmaceutical products in Hong Kong. Pharmaceutical companies can sell and supply related vaccines to private medical professionals so that they can help those in need in the private market Inoculate.

Customs Clearance Mainland｜People in Beijing: If you want to go to Hong Kong to get the bivalent vaccine of Fubitai, the protection is very good. Mainlanders can come to Hong Kong to get the bivalent vaccine of Fubitai Vaccinations for German citizens residing in China